retatrutide study news Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation It isn't approved by the
Description
These results show that retatrutide is effective in the management of type 2 diabetes and reduces the risk of cardiovascular disease
Reconstituted: refrigerate, use within 28-30 days

Mild nausea is expected and manageable
Translational Psychiatry, 12

Cardiovasc Pharmacother
It may additionally help with genital blood flow, which can improve issues like erectile dysfunction or anorgasmia
